Key result
PRECISION-COMPLEX evaluates whether OCT-guided stent optimisation improves post-PCI physiological outcomes versus angiography guidance.
Why the study?
Whether intravascular imaging-guided PCI reduces adverse events in complex coronary lesions remains debated, and the effect of OCT-guided stent optimisation on physiological PCI results has not been tested in a dedicated randomized trial.
Does OCT-guided stent optimisation reduce the proportion of patients with suboptimal post-optimisation FFR (<0.85) compared with angiography-guided PCI in adults with complex coronary artery lesions?
RCT (n=320)
Open-label
1:1
Yes
Does OCT-guided stent optimisation reduce the proportion of patients with suboptimal post-optimisation FFR (<0.85) compared with angiography-guided PCI in adults with complex coronary artery lesions?
Answers are grounded in this paper and cite their sources.
The PRECISION-COMPLEX trial protocol will determine whether algorithm-driven OCT-guided stent optimisation significantly improves the physiological outcomes of PCI (assessed by post-PCI FFR) in complex coronary lesions compared with standard angiographic guidance.
Introduction Whether intravascular imaging-guided percutaneous coronary intervention (PCI) reduces adverse events in complex coronary lesions remains debated. Although optical coherence tomography (OCT) improves stent optimisation, its effect on the physiological result of PCI has not been tested in a dedicated randomised trial. The PREcise percutaneous coronary intervention for stent OptimizatION in treatment of COMPLEX lesion (PRECISION-COMPLEX) trial aims to determine whether algorithm-driven OCT-guided stent optimisation improves the physiological result of PCI, assessed by post-optimisation fractional flow reserve (FFR), compared with angiography-guided PCI. Methods and analysis PRECISION-COMPLEX is an investigator-initiated, multicentre, open-label, superiority randomised controlled trial at four Korean academic hospitals. Patients with stable or unstable angina and at least one prespecified complex lesion are randomised 1:1 to OCT-guided or angiography-guided PCI with current-generation drug-eluting stents. In the OCT arm, stent sizing follows a prespecified algorithm, and post-PCI OCT must confirm adequate expansion, apposition and absence of major edge dissection. Post-PCI FFR is mandated in both arms. The primary endpoint is the proportion of patients with a suboptimal post-optimisation FFR (<0.85); secondary endpoints at 2 years include target-vessel failure and its components, any revascularisation and stent thrombosis. A total of 320 patients gives 90% power to detect a reduction in the primary endpoint from 30% to 15%. Enrolment ran from 15 November 2022 to 4 December 2024; follow-up is ongoing, with main results expected in early 2027. Ethics and dissemination The trial protocol was approved by the Institutional Review Board of Chonnam National University Hospital (CNUH-2022-283), the Institutional Review Board of Samsung Medical Center (SMC2022-11-012), the Institutional Review Board of Seoul National University Hospital (H2303-104-1414) and the Institutional Review Board of Chung-Ang University Gwangmyeong Hospital (2212–048-077). It conforms to the Declaration of Helsinki and Good Clinical Practice. All participants provide written informed consent. Findings will be disseminated through peer-reviewed publication and presentation at scientific meetings. PRECISION-COMPLEX will define the incremental impact of OCT-based optimisation on the physiological result of PCI and indicate whether anatomy-integrated and physiology-integrated guidance improves outcomes in complex coronary lesions. Trial registration number NCT05493904.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2026) conducted an RCT in Complex coronary artery lesions in patients with stable or unstable angina (n=320). OCT-guided stent optimisation vs. Angiography-guided PCI was evaluated on Proportion of patients with a suboptimal post-optimisation FFR (<0.85). OCT-guided stent optimisation is currently being evaluated against angiography-guided PCI in the PRECISION-COMPLEX trial to determine if it improves physiological outcomes by reducing suboptimal post-PCI FFR.
Synapse has enriched 10 related papers. Consider them for comparative context: